Cargando…

Switching TNFα inhibitors: Patterns and determinants

The aim of this study was to assess switching patterns and determinants for switching in patients initiating TNFα inhibitor (TNFα‐i) treatment. Patients were included who started TNFα‐i treatment between July 1, 2012 and December 31, 2017, from three Dutch hospitals, and were diagnosed with rheumati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meijboom, Rosanne W., Gardarsdottir, Helga, Becker, Matthijs L., de Groot, Mark C. H., Movig, Kris L. L., Kuijvenhoven, Johan, Egberts, Toine C. G., Leufkens, Hubert G. M., Giezen, Thijs J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305431/ https://www.ncbi.nlm.nih.gov/pubmed/34302442 http://dx.doi.org/10.1002/prp2.843

Ejemplares similares

Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar
por: Meijboom, Rosanne W., et al.
Publicado: (2023)

Patients Retransitioning from Biosimilar TNFα Inhibitor to the Corresponding Originator After Initial Transitioning to the Biosimilar: A Systematic Review
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

Regulatory Safety Learning Driven by the Mechanism of Action: The Case of TNF‐α Inhibitors
por: Minnema, Lotte A., et al.
Publicado: (2020)

Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

Type and Extent of Information on (Potentially Critical) Quality Attributes Described in European Public Assessment Reports for Adalimumab Biosimilars
por: Alsamil, Ali M., et al.
Publicado: (2021)

Exploring the Association between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A VigiBase Study
por: Minnema, Lotte A., et al.
Publicado: (2019)

Post‐marketing dosing changes in the label of biologicals
por: Minnema, Lotte A., et al.
Publicado: (2019)

Adverse events related to biologicals used for patients with multiple sclerosis: a comparison between information originating from regulators and information originating from the scientific community
por: Minnema, L. A., et al.
Publicado: (2020)

Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study
por: Arbouw, Maurits E. L., et al.
Publicado: (2011)

Reply: long-term retention rate of pramipexole in the treatment of Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Willingness of patients to use unused medication returned to the pharmacy by another patient: a cross-sectional survey
por: Bekker, Charlotte, et al.
Publicado: (2019)

Enabling appropriate use of antibiotics: review of European Union procedures of harmonising product information, 2007 to 2020
por: Opalska, Aleksandra, et al.
Publicado: (2020)

The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription
por: Beers, Erna, et al.
Publicado: (2013)

Older Patients’ Compliance with Drug Storage Recommendations
por: Vlieland, Nicolaas D., et al.
Publicado: (2018)

Companies’ Health Technology Assessment Strategies and Practices in Australia, Canada, England, France, Germany, Italy and Spain: An Industry Metrics Study
por: Wang, Ting, et al.
Publicado: (2020)

Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase
por: Willemen, Marjolein J., et al.
Publicado: (2011)

Practical Problems with Medication Use that Older People Experience: A Qualitative Study
por: Notenboom, Kim, et al.
Publicado: (2014)

Predicting rehospitalization in patients treated with antipsychotics: a prospective observational study
por: Abdullah-Koolmees, Heshu, et al.
Publicado: (2018)

Pharmacists’ Activities to Reduce Medication Waste: An International Survey
por: Bekker, Charlotte L., et al.
Publicado: (2018)

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Are Further Interventions Needed to Prevent and Manage Hospital-Acquired Hyponatraemia? A Nationwide Cross-Sectional Survey of IV Fluid Prescribing Practices
por: Sindahl, Per, et al.
Publicado: (2020)

What does it cost to redispense unused medications in the pharmacy? A micro-costing study
por: Bekker, Charlotte L., et al.
Publicado: (2019)

Use of Real‐World Data and Evidence in Drug Development of Medicinal Products Centrally Authorized in Europe in 2018–2019
por: Eskola, Sini Marika, et al.
Publicado: (2021)

Prescribing patterns and compliance with World Health Organization recommendations for the management of severe malaria: a modified cohort event monitoring study in public health facilities in Ghana and Uganda
por: Ampadu, H. Hilda, et al.
Publicado: (2019)

QTc Prolongation in COVID-19 Patients Using Chloroquine
por: Becker, Matthijs L., et al.
Publicado: (2021)

Dopaminergic drugs and the risk of hip or femur fracture: a population-based case–control study
por: Arbouw, M. E. L., et al.
Publicado: (2010)

Distinct Profiles on Subjective and Objective Adherence Measures in Patients Prescribed Antidepressants
por: Wouters, Hans, et al.
Publicado: (2019)

Patient and medication factors associated with preventable medication waste and possibilities for redispensing
por: Bekker, C. L., et al.
Publicado: (2018)

The effect of non-adherence to antipsychotic treatment on rehospitalization in patients with psychotic disorders
por: Abdullah-Koolmees, H., et al.
Publicado: (2021)

Effect of reimbursement restriction policy on the use of benzodiazepines in the Netherlands: an interrupted time series analysis
por: Stoker, Lennart Jan, et al.
Publicado: (2019)

Safety Experience During Real-World Use of Injectable Artesunate in Public Health Facilities in Ghana and Uganda: Outcomes of a Modified Cohort Event Monitoring Study (CEMISA)
por: Ampadu, H. Hilda, et al.
Publicado: (2018)

Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia
por: van Geijlswijk, Ingeborg M., et al.
Publicado: (2011)

Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug
por: Hyrich, K. L., et al.
Publicado: (2008)

Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity
por: Zillen, Daan, et al.
Publicado: (2021)

Antipsychotic use and the risk of hip/femur fracture: a population-based case–control study
por: Pouwels, S., et al.
Publicado: (2009)

Loss of XIAP facilitates switch to TNFα-induced necroptosis in mouse neutrophils
por: Wicki, Simone, et al.
Publicado: (2016)

Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?
por: Manica, Santiago Rodrigues, et al.
Publicado: (2020)

Monitoring of Adverse Drug Reaction-Related Parameters in Children and Adolescents Treated With Antipsychotic Drugs in Psychiatric Outpatient Clinics
por: Minjon, Lenneke, et al.
Publicado: (2021)

Long-Term Melatonin Therapy for Adolescents and Young Adults with Chronic Sleep Onset Insomnia and Late Melatonin Onset: Evaluation of Sleep Quality, Chronotype, and Lifestyle Factors Compared to Age-Related Randomly Selected Population Cohorts
por: Zwart, Tom C., et al.
Publicado: (2018)

The effect of a decision support system on the incidence of prescription errors in a PICU
por: Hashemi, Fatema, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ut4em5ii90nj00mas73vs2v9vj